The ICH E6(R3) “Good Clinical Practice” Guideline provides a unified standard to facilitate the mutual acceptance of clinical [...]
Alpha-9 funds targeted radiopharmaceuticals; Evommune pursues chronic urticaria and atopic dermatitis; Agomab Therapeutics advances lead candidate [...]
Adding Merck & Co.’s new cardiovascular drug Winrevair to background therapy helped people with severe lung [...]
Sleep-disordered breathing (SDB) affects 60% of patients with stroke, with prevalence ranging from 57% in North [...]
Data readouts over the next six months could set expectations for how the highly lucrative market [...]
SAN FRANCISCO — While the physical toll of cancer is well documented, the financial toll can [...]
New treatment option for patients with newly diagnosed multiple myeloma The European Commission has approved the [...]
The two-year programme will use virtual reality technology to teach essential skills A £4.5m initiative has [...]
A groundbreaking new approach for treating triple-negative breast cancer (TNBC) is moving forward, thanks to discoveries [...]
BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their [...]